skip to Main Content

Identification of LIPH as an Unfavorable Biomarkers Correlated with Immune Suppression or Evasion in Pancreatic Cancer Based on RNA-seq

Newsfeed image, light gray text on dark gray background
It is widely considered that pancreatic cancer (PC) is an immunosuppressive cancer. Immune-based therapies remain promising therapeutic strategies for PC.

Overexpression of lipase H (LIPH) was reported to be related to immunity in cattle and has also been demonstrated to promote tumor progression in several tumors, but its role in pancreatic carcinogenesis remains unclear. Study on LIPH in PC might provide a new insight into the immunosuppression in PC. Read more . . . 


Back To Top